The Emirate of Sharjah and Canada have signed a new health MoU

By Catherine Sturman
Sharjah and Canada have inked a new five-year agreement in which to share best practices in the delivery of healthcare services and undertake a large nu...

Sharjah and Canada have inked a new five-year agreement in which to share best practices in the delivery of healthcare services and undertake a large number of projects to provide care that it of the highest standard.

Sharjah has been transforming its healthcare services since 2012, with the ongoing Sharjah Healthcare City (SHCC) project. It will see the region attract new talent, and is expected to complete by 2020, costing AED 600 million.

Sharjah Healthcare City is situated in close proximity to both Sharjah and Dubai Airports, and will operate as a Free Zone, which will enable investors to own 100% of entities, whilst adopting a world-class infrastructure.

Health stories

The city is also looking to further open up further growth through medical tourism.

The agreement will pave the way for further investment, and will see a new hospital built in Sharjah, costing approximately AED 1 billion. It will focus on paediatric, obstetrics and gynaecological services. The project also incorporates a research centre dedicated to paediatric care and adopt international standards.

Her Highness Sheikha Jawaher Al Qasimi has said, “Sharjah regards medical excellence as one of its primary priorities and is committed to achieving an unrivalled healthcare environment, from infrastructure and health facilities to management strategies and elite medical staff.”

The World Health Organisation has ranked the UAE among the world’s top 30 countries in terms of the performance of healthcare systems.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare